Elos Medtech - Year-end Report, 1 January - 31 December, 2022
October – December 2022 · Net sales for the fourth quarter amounted to SEK 229.5 (184.2) million, an increase of 24.6 percent compared to the same quarter last year. Net sales in local currencies increased by 13.8 percent. · Operating profit amounted to SEK 17.6 (25.3) million, corresponding to an operating margin of 7.7 (13.7) percent. · Profit after net financial items amounted to SEK 1.4 (24.8) million. Net financial items were negatively affected by exchange rates of SEK -8.3 (1.2) million and totaled SEK -16.3 (-0.5) million. · Profit after tax amounted to SEK 0.4 (19.5)